Sale!

NTRK1 Test Cost

Original price was: 2,400 د.إ.Current price is: 1,800 د.إ.

-25%

The NTRK1 Test is a specialized diagnostic procedure designed to detect alterations in the NTRK1 gene, which can play a crucial role in the development and progression of various cancers. This gene encodes for a protein that is involved in the growth and division of cells, and mutations in NTRK1 can lead to abnormal cell growth, potentially resulting in cancer. The test is particularly significant for patients with tumors that may be driven by NTRK gene fusions, as it can help in guiding targeted therapy options.

Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the NTRK1 Test is performed using sophisticated molecular techniques to ensure accuracy and reliability. The cost of the test is 1800 AED, reflecting the comprehensive analysis and detailed insights it provides. By identifying NTRK1 gene alterations, healthcare providers can tailor treatment strategies more effectively, offering hope for better outcomes in patients affected by cancers associated with these genetic changes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NTRK1 Test Cost AED:1800.0 – Symptoms, Diagnosis, and More

At DNA Labs UAE, we offer the NTRK1 test for AED 1800.0. This test is designed to diagnose genetic disorders and identify gene fusions in various types of cancer. Read on to learn more about the test and its components.

Test Name: NTRK1 Test

Components: Paraffin embedded tissue blocks

Price: 1800.0 AED

Sample Condition: Tumor tissue

Report Delivery: 7-8 days

Method: FISH

Test Type: Genetics

Doctor: Oncology

Test Department: Pre Test Information

NTRK1 can be done with a Doctor’s prescription. However, prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

The NTRK1 test focuses on a gene that provides instructions for making a protein called neurotrophic tyrosine kinase receptor 1. This protein acts as a receptor for a group of proteins known as neurotrophins, which are involved in the development and function of nerve cells.

One of the conditions associated with mutations in the NTRK1 gene is congenital insensitivity to pain with anhidrosis (CIPA). Individuals with CIPA lack the ability to feel pain, heat, or cold, and may also have reduced sweating capabilities. This condition can lead to injuries and other health issues, as affected individuals are unable to sense and respond to potential dangers.

Furthermore, NTRK1 gene fusions have been identified in various types of cancer, particularly in rare cancers such as secretory breast carcinoma, mammary analogue secretory carcinoma of the salivary glands, and infantile fibrosarcoma. These gene fusions result in the abnormal activation of the NTRK1 protein, leading to uncontrolled cell growth and tumor formation.

The discovery of NTRK1 gene fusions in cancer has paved the way for targeted therapies that specifically inhibit the activity of the abnormal NTRK1 protein. Clinical trials have shown promising results, offering new treatment options for patients with NTRK1 fusion-positive cancers.

If you suspect a genetic disorder or need to diagnose gene fusions in cancer, our NTRK1 test can provide valuable insights. Contact DNA Labs UAE today to schedule an appointment.

Test Name NTRK1 Test
Components Paraffin embedded tissue blocks
Price 1800.0 AED
Sample Condition Tumor tissue
Report Delivery 7-8 days
Method FISH
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information NTRK1 can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

NTRK1 is a gene that provides instructions for making a protein called neurotrophic tyrosine kinase receptor 1. This protein is a receptor for a group of proteins called neurotrophins, which play a role in the development and function of nerve cells.

Mutations in the NTRK1 gene can cause a rare genetic disorder called congenital insensitivity to pain with anhidrosis (CIPA). Individuals with CIPA are unable to feel pain, heat, or cold, and they may also have a decreased ability to sweat. This condition can lead to injuries and other health problems, as affected individuals are unable to sense and respond to potentially dangerous stimuli.

In addition to its role in CIPA, NTRK1 gene fusions have been found in various types of cancer, particularly in rare cancers such as secretory breast carcinoma, mammary analogue secretory carcinoma of the salivary glands, and infantile fibrosarcoma. These gene fusions result in the abnormal activation of the NTRK1 protein, leading to uncontrolled cell growth and tumor formation.

The discovery of NTRK1 gene fusions in cancer has led to the development of targeted therapies that specifically inhibit the activity of the abnormal NTRK1 protein. These targeted therapies have shown promising results in clinical trials, providing a new treatment option for patients with NTRK1 fusion-positive cancers.